Related Experiment Videos
Glucose-6-phosphate dehydrogenase status and neonatal jaundice
Insights
Neonatal jaundice is common in infants, but glucose-6-phosphate dehydrogenase (G6PD) deficiency can worsen it. G6PD-deficient infants require close monitoring during the first week of life due to increased jaundice risk.
Area of Science:
- Neonatal Medicine
- Pediatric Hematology
- Genetics
Background:
- Neonatal jaundice is a common clinical condition.
- Glucose-6-phosphate dehydrogenase (G6PD) deficiency is an inherited condition affecting red blood cells.
- The impact of G6PD status on neonatal jaundice in healthy, term infants requires further elucidation.
Purpose of the Study:
- To evaluate the relationship between G6PD status and neonatal jaundice in healthy, term Chinese infants.
- To determine the specific risks associated with G6PD deficiency and intermediate status regarding jaundice severity and duration.
Main Methods:
- A cohort study involving 220 G6PD-deficient, 26 G6PD-intermediate, and 116 normal (control) healthy, term Chinese infants.
- Exclusion of infants with isoimmunisation, cephalhaematomas, or contusions.
- Daily bilirubin level monitoring over a 3-week observation period.
Main Results:
- G6PD deficiency was significantly associated with raised jaundice, particularly in the first week of life, and prolonged jaundice compared to physiological levels.
- Mild hemolysis was significantly increased in G6PD-deficient infants.
- Mode of labor, delivery method, and feeding type did not significantly affect daily bilirubin levels.
- G6PD-intermediate infants showed no increased risk beyond that of normal infants.
Conclusions:
- G6PD-deficient infants require close surveillance for at least the first week of life due to increased risk of severe and prolonged jaundice.
- G6PD-intermediate infants do not necessitate special monitoring beyond routine care for normal newborns.
Abstract:
Neonatal jaundice and its relationship to glucose-6-phosphate dehydrogenase (G6PD) status of healthy, term Chinese infants was evaluated in 220 G6PD-deficient infants, 26 intermediate infants who were observed for 3 weeks, and 116 normal (control) infants. Each infant was free of isoimmunisation, cephalhaematomas, or contusions. The mode of labour, method of delivery, and type of feeds had no appreciable effect on daily bilirubin levels. "Elevated" physiological jaundice was associated with normal and G6PD-deficient status; there was no increased haemolysis. G6PD-deficient status was associated with jaundice significantly raised especially in the first week of life, and prolonged beyond that of the "elevated" physiological jaundice. Significantly increased though mild haemolysis was observed. Close surveillance is therefore required for G6PD-deficient infants at least for the first week of life, the period of increased risk. With G6PD-intermediate infants, only the usual measures for normal infants are required.